The chemical compound indazole chloride (Ind-Cl) initiated long lasting relief in mice models of multiple sclerosis.
The FDA issued a safety warning for the MS drug Tecfidera after a patient died from a rare brain disease while taking no other medications.
Results from a study published in the International Journal of MS Care suggest that magnetic resonance imaging may be used to identify asymptomatic patients who are at higher risk for developing multiple sclerosis.
Could multiple sclerosis be caused by a “rogue protein” that attacks the central nervous system? That’s the hypothesis of a research team from the University of Surrey, Guildford, UK and researchers at the University of Texas Houston Medical School’s Mitchell Center for Alzheimer’s Disease and Related Brain Disorders.
Multiple sclerosis (MS) patients and their neurologists noted some discomfort in discussing MS symptoms, found a survey presented at the ACTRIMS-ECTRIMS conference in September.
Multiple sclerosis flare-ups in animal models were blocked after a protein treatment, according to a study published in Molecular Psychiatry.